Transcription of 国際腹膜透析学会(ISPD)ガイドライン/勧告
{{id}} {{{paragraph}}}
Peritoneal Dialysis International, Vol. 36, pp. 481 $ + .00 Copyright 2016 International Society for Peritoneal Dialysis481 ISPD 2016 Philip Kam-Tao Li,1 Cheuk Chun Szeto,1 Beth Piraino,2 Javier de Arteaga,3 Stanley Fan,4 Ana E. Figueiredo,5 Douglas N. Fish,6 Eric Goffin,7 Yong-Lim Kim,8 William Salzer,9 Dirk G. Struijk,10 Isaac Teitelbaum,11 and David W. Johnson12 Department of Medicine and Therapeutics,1 Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong; University of Pittsburgh School of Medicine,2 Pittsburgh, PA, USA; Department of Nephrology,3 Hospital Privado and Catholic University, Cordoba, Argentina; Department of Renal Medicine and Transplantation,4 Barts Health NHS Trust, London, UK; Nursing School-FAENFI,5 Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, Brazil; Department of Clinical Pharmacy,6 Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO, USA; Department of Nephrology,7 Cliniques Universitaires Saint-Luc, Universit catholique de Louvain, Belgium; Department of Internal Medicine,8 Kyungpook National University School of Medicine, Clinical Research Center for End Stage Renal Disease, Daegu, Korea.
482 li et al. seteber 2016 ol 36, no 5 pdi うものではないことを付記する。具体的には各施設にお いてそれぞれの感染の状況、起炎菌、感受性について検
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}